LVZP.F logo

Livzon Pharmaceutical Group OTCPK:LVZP.F Stock Report

Last Price

US$3.11

Market Cap

US$4.4b

7D

0%

1Y

n/a

Updated

26 Jul, 2023

Data

Company Financials +

Livzon Pharmaceutical Group Inc.

OTCPK:LVZP.F Stock Report

Market Cap: US$4.4b

LVZP.F Stock Overview

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.

LVZP.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Livzon Pharmaceutical Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Livzon Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥3.11
52 Week HighCN¥3.11
52 Week LowCN¥2.55
Beta0.43
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change-32.68%
Change since IPO-32.68%

Recent News & Updates

Recent updates

Shareholder Returns

LVZP.FUS PharmaceuticalsUS Market
7D0%1.2%0.4%
1Yn/a25.8%28.8%

Return vs Industry: Insufficient data to determine how LVZP.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how LVZP.F performed against the US Market.

Price Volatility

Is LVZP.F's price volatile compared to industry and market?
LVZP.F volatility
LVZP.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: LVZP.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LVZP.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19859,005Yanggang Tanghttps://www.livzon.com.cn

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody.

Livzon Pharmaceutical Group Inc. Fundamentals Summary

How do Livzon Pharmaceutical Group's earnings and revenue compare to its market cap?
LVZP.F fundamental statistics
Market capUS$4.41b
Earnings (TTM)US$271.03m
Revenue (TTM)US$1.76b

18.5x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LVZP.F income statement (TTM)
RevenueCN¥12.56b
Cost of RevenueCN¥4.66b
Gross ProfitCN¥7.90b
Other ExpensesCN¥5.97b
EarningsCN¥1.94b

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Aug 24, 2023

Earnings per share (EPS)2.08
Gross Margin62.91%
Net Profit Margin15.43%
Debt/Equity Ratio26.1%

How did LVZP.F perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

77%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.